Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | FLT3 | P36888 | 1/20 | 0.31 |
| ▸ | GSK3A | P49840 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.31 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | APAF1 | O14727 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL191346 | 0.70 | IDO1 (0.40) | IDO1LMNAHSP90AA1MAPTSMN1; SMN2 | |
| SCHEMBL30565769 | 0.70 | — | — | |
| SCHEMBL14455165 | 0.70 | MAPK1 (0.44) | IDO1LMNAHSP90AA1MAPTSMN1; SMN2 | |
| SCHEMBL29349590 | 0.70 | IDO1 (0.40) | IDO1LMNAHSP90AA1MAPTSMN1; SMN2 | |
| SCHEMBL18862390 | 0.69 | ACHE (0.30) | IDO1 | |
| SCHEMBL9959991 | 0.69 | IDO1 (0.39) | IDO1LMNAHSP90AA1MAPTSMN1; SMN2 | |
| SCHEMBL528427 | 0.68 | IDO1 (0.32) | IDO1LMNAHSP90AA1MAPTSMN1; SMN2 | |
| SCHEMBL18862222 | 0.66 | IDO1 (0.34) | IDO1CYP1A2CYP2D6 | |
| SCHEMBL14455164 | 0.65 | MAPK1 (0.44) | IDO1LMNAHSP90AA1MAPTSMN1; SMN2 | |
| SCHEMBL25431743 | 0.65 | ALDH1A1 (0.36) | IDO1LMNAHSP90AA1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9184391-B2 | Compound having indolocarbazole moiety and divalent linkage | XEROX CORPORATION (US) | 2015-11-10 | — | — | US | disclosed |
| US-20140148567-A1 | COMPOUND HAVING INDOLOCARBAZOLE MOIETY AND DIVALENT LINKAGE | XEROX CORPORATION (US) | 2014-05-29 | — | — | US | disclosed |
| US-20140088313-A1 | SUBSTITUTED INDOLOCARBAZOLES | XEROX CORPORATION (US) | 2014-03-27 | — | — | US | disclosed |
| US-8673959-B2 | Polymer having indolocarbazole moiety and divalent linkage | XEROX CORPORATION (US) | 2014-03-18 | — | — | US | disclosed |
| US-8609867-B2 | Substituted indolocarbazoles | XEROX CORPORATION (US) | 2013-12-17 | — | — | US | disclosed |
| EP-1671998-B1 | Process to form compound with indolocarbazole moieties | XEROX CORP (US) | 2013-02-20 | — | — | EP | disclosed |
| US-20120157689-A1 | SUBSTITUTED INDOLOCARBAZOLES | XEROX CORPORATION (US) | 2012-06-21 | — | — | US | disclosed |
| US-8110690-B2 | Substituted indolocarbazoles | XEROX CORPORATION (US) | 2012-02-07 | — | — | US | disclosed |
| US-8003807-B2 | organic thin film transistor with a semiconductor layer including the small molecule having didodecylindolo[3,2-b]carbazole groups | XEROX CORPORATION (US) | 2011-08-23 | — | — | US | disclosed |
| US-7868186-B2 | Device containing polymer having indolocarbazole- repeat unit and divalent linkage | XEROX CORPORATION (US) | 2011-01-11 | — | — | US | disclosed |
| US-20070112167-A1 | Device containing compound having indolocarbazole moiety and divalent linkage | XEROX CORPORATION | 2007-05-17 | — | — | US | disclosed |
| US-20070112172-A1 | Compound having indolocarbazole moiety and divalent linkage | XEROX CORPORATION | 2007-05-17 | — | — | US | disclosed |
| US-7173140-B2 | Process to form compound with indolocarbazole moieties | XEROX CORPORATION (US) | 2007-02-06 | — | — | US | disclosed |
| US-20060214155-A1 | Compound with indolocarbazole moieties and devices containing such compound | XEROX CORPORATION | 2006-09-28 | — | — | US | disclosed |
| EP-1672713-A1 | Compound with indolocarbazole moieties and electronic devices containing such compound | Xerox Corporation (US) | 2006-06-21 | — | — | EP | disclosed |
| EP-1671998-A2 | Process to form compound with indolocarbazole moieties | Xerox Corporation (US) | 2006-06-21 | — | — | EP | disclosed |
| US-20060124923-A1 | Thin film transistors including indolocarbazoles | XEROX CORPORATION | 2006-06-15 | — | — | US | disclosed |
| US-20060124921-A1 | Compound with indolocarbazole moieties and devices containing such compound | XEROX CORPORATION (US) | 2006-06-15 | — | — | US | disclosed |
| US-20060125009-A1 | Thin film transistors including indolocarbazoles | XEROX CORPORATION | 2006-06-15 | — | — | US | disclosed |
| US-20060128969-A1 | Process to form compound with indolocarbazole moieties | XEROX CORPORATION | 2006-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070112172-A1 | Compound having indolocarbazole moiety and divalent linkage | INMT, IDO2, GRIN2C | IDO1 7/4885LMNA 3087/4885HSP90AA1 3868/4885 |
| US-20060128969-A1 | Process to form compound with indolocarbazole moieties | INMT, CYP3A4, PLK1 | IDO1 4/4885LMNA 2632/4885HSP90AA1 2874/4885 |
| US-20060214155-A1 | Compound with indolocarbazole moieties and devices containing such compound | BRD4, INO80C, BICRA | IDO1 26/4885LMNA 3795/4885HSP90AA1 3986/4885 |
| US-20060124921-A1 | Compound with indolocarbazole moieties and devices containing such compound | BRD4, INO80C, BICRA | IDO1 26/4885LMNA 3795/4885HSP90AA1 3986/4885 |
| US-20120157689-A1 | SUBSTITUTED INDOLOCARBAZOLES | HTR3C, HTR3A, AANAT | IDO1 15/4885LMNA 3353/4885HSP90AA1 2623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.